reading re: mayne pharma recent results it was stated that USA income down due to the higher level of generic competition there. ACR will be late comer to the situation so no doubt they will have issues breaking into the market one would assume - maybe that's what the market saw last week - all IMO
- Forums
- ASX - By Stock
- Letter from Samuel Terry Asset Mgt re AGM
ACR
acrux limited
Add to My Watchlist
0.00%
!
2.1¢

reading re: mayne pharma recent results it was stated that USA...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.594M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $1.922K | 91.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 816823 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 400000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 816823 | 0.017 |
12 | 945798 | 0.016 |
8 | 2545214 | 0.015 |
3 | 240000 | 0.014 |
2 | 386850 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 400000 | 1 |
0.021 | 111922 | 1 |
0.022 | 100000 | 1 |
0.023 | 381179 | 1 |
0.024 | 201073 | 3 |
Last trade - 11.56am 23/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |